USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration

International Journal of Cancer

Volumn 136, Issue 8, 2015, Pages 1792-1802

  Huang, Zhaohui ^a,b   Wen, Pushuai ^c   Kong, Ruirui ^c   Cheng, Haipeng ^b   Zhang, Binbin ^a   Quan, Cao ^a   Bian, Zehua ^a   Chen, Mengmeng ^c   Zhang, Zhenfeng ^d   Chen, Xiaoping ^b   Du, Xiang ^e   Liu, Jianghong ^c   Zhu, Li ^c   Fushimi, Kazuo ^b   Hua, Dong ^a   Wu, Jane Y ^b,c  

^a JIANGNAN UNIVERSITY   (China)

^b NORTHWESTERN UNIVERSITY   (United States)

^c INSTITUTE OF BIOPHYSICS   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Cell migration; Colorectal cancer; Robo1; Slit2; USP33

Indexed keywords

MESSENGER RNA; ROUNDABOUT RECEPTOR; SLIT2 PROTEIN; IMMUNOGLOBULIN RECEPTOR; NERVE PROTEIN; SIGNAL PEPTIDE; SLIT HOMOLOG 2 PROTEIN; UBIQUITIN THIOLESTERASE; USP33 PROTEIN, HUMAN;

ARTICLE; CANCER GRADING; CANCER INHIBITION; CANCER SURVIVAL; CANCER TISSUE; CELL MIGRATION; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE INTERACTION; GENETIC STABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; LYMPH NODE METASTASIS; PROMOTER REGION; RNA METHYLATION; ROBO1 GENE; SIGNAL TRANSDUCTION; SLIT2 GENE; TUMOR GENE; UBIQUITINATION; USP33 GENE; CACO 2 CELL LINE; CELL LINE; CELL MOTION; COLORECTAL TUMOR; DNA METHYLATION; GENETICS; HCT116 CELL LINE; HEK293 CELL LINE; HT 29 CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

CACO-2 CELLS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DNA METHYLATION; DOWN-REGULATION; GENES, TUMOR SUPPRESSOR; HCT116 CELLS; HEK293 CELLS; HT29 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHATIC METASTASIS; NERVE TISSUE PROTEINS; PROMOTER REGIONS, GENETIC; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; UBIQUITIN THIOLESTERASE;

EID: 84922553110     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29226     Document Type: Article

References (42)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: Cancer J Clin 2013;63:11-30.
2. Brose K, Bland KS, Wang KH, et al. Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 1999;96:795-806.
3. Kidd T, Bland KS, Goodman CS. Slit is the midline repellent for the robo receptor in Drosophila. Cell 1999;96:785-94.
4. Wu W, Wong K, Chen J, et al. Directional guidance of neuronal migration in the olfactory system by the protein slit. Nature 1999;400:331-6.
5. Li HS, Chen JH, Wu W, et al. Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons. Cell 1999;96:807-18.
6. Ballard MS, Hinck L. A roundabout way to cancer. Adv Cancer Res 2012;114:187-235.
7. Dickinson RE, Dallol A, Bieche I, et al. Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. Br J Cancer 2004;91:2071-8.
8. Dallol A, Morton D, Maher ER, et al. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 2003;63:1054-8.
9. Zhou WJ, Geng ZH, Chi S, et al. Slit-Robo signaling induces malignant transformation through Hakai-mediated E-cadherin degradation during colorectal epithelial cell carcinogenesis. Cell Res 2011;21:609-26.
10. Chen WF, Gao WD, Li QL, et al. SLIT2 inhibits cell migration in colorectal cancer through the AKT-GSK3beta signaling pathway. Int J Colorectal Dis 2013;28:933-40.
11. Yuasa-Kawada J, Kinoshita-Kawada M, Rao Y, et al. Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration. Proc Natl Acad Sci USA 2009;106:14530-5.
12. Yuasa-Kawada J, Kinoshita-Kawada M, Wu G, et al. Midline crossing and Slit responsiveness of commissural axons require USP33. Nat Neurosci 2009;12:1087-9.
13. Wong K, Ren XR, Huang YZ, et al. Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 2001;107:209-21.
14. Li Z, Na X, Wang D, et al. Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein. J Biol Chem 2002;277:4656-62.
15. Herman JG, Graff JR, Myohanen S, et al. Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
16. Ward ME, Rao Y. Investigations of neuronal migration in the central nervous system. Methods Mol Biol 2005;294:137-56.
17. Wang Q, Huang Z, Guo W, et al. MicroRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma. Clin Cancer Res 2014;20:1146-57.
18. Sheffer M, Bacolod MD, Zuk O, et al. Association of survival and disease progression with chromosomal instability: a genomic exploration of colorectal cancer. Proc Natl Acad Sci USA 2009;106:7131-6.
19. Dallol A, Krex D, Hesson L, et al. Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 2003;22:4611-6.
20. Dallol A, Da Silva NF, Viacava P, et al. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 2002;62:5874-80.
21. Sundaresan V, Chung G, Heppell-Parton A, et al. Homozygous deletions at 3p12 in breast and lung cancer. Oncogene 1998;17:1723-9.
22. Shivapurkar N, Virmani AK, Wistuba, II, et al. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin Cancer Res 1999;5:17-23.
23. Shivapurkar N, Sood S, Wistuba, II, et al. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res 1999;59:3576-80.
24. Singh RK, Indra D, Mitra S, et al. Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene. Hum Genet 2007;122:71-81.
25. Astuti D, Da Silva NF, Dallol A, et al. SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma. Br J Cancer 2004;90:515-21.
26. Narayan G, Goparaju C, Arias-Pulido H, et al. Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer 2006;5:16.
27. Beggs AD, Jones A, El-Bahwary M, et al. Wholegenome methylation analysis of benign and malignant colorectal tumours. J Pathol 2013;229:697-704.
28. Carmona FJ, Azuara D, Berenguer-Llergo A, et al. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev Res 2013;6:656-65.
29. Yu J, Cao Q, Wu L, et al. The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. Oncogene 2010;29:5370-80.
30. Latil A, Chene L, Cochant-Priollet B, et al. Quantification of expression of netrins, slits and their receptors in human prostate tumors. Int J Cancer 2003;103:306-15.
31. Wang LJ, Zhao Y, Han B, et al. Targeting Slit-Roundabout signaling inhibits tumor angiogenesis in chemical-induced squamous cell carcinogenesis. Cancer Sci 2008;99:510-7.
32. Bashaw GJ, Kidd T, Murray D, et al. Repulsive axon guidance: Abelson and Enabled play opposing roles downstream of the roundabout receptor. Cell 2000;101:703-15.
33. Fan X, Labrador JP, Hing H, et al. Slit stimulation recruits Dock and Pak to the roundabout receptor and increases Rac activity to regulate axon repulsion at the CNS midline. Neuron 2003;40:113-27.
34. Wu JY, Feng L, Park HT, et al. The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factors. Nature 2001;410:948-52.
35. Lundstrom A, Gallio M, Englund C, et al. Vilse, a conserved Rac/Cdc42 GAP mediating Robo repulsion in tracheal cells and axons. Genes Dev 2004;18:2161-71.
36. Curcio-Morelli C, Zavacki AM, Christofollete M, et al. Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J Clin Invest 2003;112:189-96.
37. Berthouze M, Venkataramanan V, Li Y, et al. The deubiquitinases USP33 and USP20 coordinate beta2 adrenergic receptor recycling and resensitization. EMBO J 2009;28:1684-96.
38. Jeong JY, Wang Y, Sytkowski AJ. Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner. Biochem Biophys Res Commun 2009;379:583-8.
39. Shenoy SK, Modi AS, Shukla AK, et al. Betaarrestindependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2. Proc Natl Acad Sci U S A 2009;106:6650-5.
40. Simicek M, Lievens S, Laga M, et al. The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response. Nat Cell Biol 2013;15:1220-30.
41. Li J, D'Angiolella V, Seeley ES, et al. USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110. Nature 2013;495:255-9.
42. Prasad A, Paruchuri V, Preet A, et al. Slit-2 induces a tumor-suppressive effect by regulating betacatenin in breast cancer cells. J Biol Chem 2008;283:26624-33.